专利检索 ap:("IGNYTA, INC.") AND inv:"Stephen J. Bierlmaier" 第 1 页

1.

发明申请
SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITOR 有权
标题翻译：喹啉衍生物的固体形态及其作为BRAF抑制剂的用途

公开(公告)号：US20150376171A1

公开(公告)日：2015-12-31

申请号：US14746666

申请日：2015-06-22

申请人： Ignyta, Inc.

发明人： Stephen J. Bierlmaier , Ralph C. Haltiwanger , Martin J. Jacobs

IPC分类号： C07D413/12 , A61K9/48 , A61K9/20

CPC分类号： A61K31/517 , A61K9/20 , A61K9/48 , C07B2200/13 , C07C55/08 , C07D239/88 , C07D413/12

摘要： This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.

摘要翻译： 本申请涉及化合物（I）的各种盐和固体形式。本申请还涉及这些材料和组合物的药物组合物和治疗用途。

2.

发明授权
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor 有权

公开(公告)号：US09987281B2

公开(公告)日：2018-06-05

申请号：US15632248

申请日：2017-06-23

申请人： IGNYTA, INC.

发明人： Stephen J. Bierlmaier , Ralph C. Haltiwanger , Martin J. Jacobs

IPC分类号： A61K31/517 , C07D413/12

CPC分类号： A61K31/517 , A61K9/20 , A61K9/48 , C07B2200/13 , C07C55/08 , C07D239/88 , C07D413/12

摘要： This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.

3.

发明授权
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor 有权
标题翻译：喹唑啉衍生物的固态形式及其作为BRAF抑制剂的用途

公开(公告)号：US09353097B2

公开(公告)日：2016-05-31

申请号：US14746666

申请日：2015-06-22

申请人： Ignyta, Inc.

发明人： Stephen J. Bierlmaier , Ralph C. Haltiwanger , Martin J. Jacobs

IPC分类号： C07D413/12 , A61K31/517 , C07D239/88 , A61K9/20 , A61K9/48

CPC分类号： A61K31/517 , A61K9/20 , A61K9/48 , C07B2200/13 , C07C55/08 , C07D239/88 , C07D413/12

摘要： This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.

摘要翻译： 本申请涉及化合物（I）的各种盐和固体形式。本申请还涉及这些材料和组合物的药物组合物和治疗用途。

4.

发明授权
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor 有权

公开(公告)号：US09718810B2

公开(公告)日：2017-08-01

申请号：US15137922

申请日：2016-04-25

申请人： Ignyta, Inc.

发明人： Stephen J. Bierlmaier , Ralph C. Haltiwanger , Martin J. Jacobs

IPC分类号： C07D413/12 , A61K31/517 , C07D239/88 , A61K9/20 , A61K9/48 , C07C55/08

CPC分类号： A61K31/517 , A61K9/20 , A61K9/48 , C07B2200/13 , C07C55/08 , C07D239/88 , C07D413/12

摘要： This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.

5.

发明申请
SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITOR 有权

公开(公告)号：US20160280698A1

公开(公告)日：2016-09-29

申请号：US15137922

申请日：2016-04-25

申请人： Ignyta, Inc.

发明人： Stephen J. Bierlmaier , Ralph C. Heltiwanger , Martin J. Jacobs

IPC分类号： C07D413/12 , C07C55/08

CPC分类号： A61K31/517 , A61K9/20 , A61K9/48 , C07B2200/13 , C07C55/08 , C07D239/88 , C07D413/12

摘要： This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.